M. (2015). Sparse feature selection methods identify unexpected global cellular response to strontium-containing materials.
Despite the increasing sophistication of biomaterials design and functional characterization studies, little is known regarding cells' global response to biomaterials. Here, we combined nontargeted holistic biological and physical science techniques to evaluate how simple strontium ion incorporation within the well-described biomaterial 45S5 bioactive glass (BG) influences the global response of human mesenchymal stem cells. Our objective analyses of whole gene-expression profiles, confirmed by standard molecular biology techniques, revealed that strontium-substituted BG up-regulated the isoprenoid pathway, suggesting an influence on both sterol metabolite synthesis and protein prenylation processes. This upregulation was accompanied by increases in cellular and membrane cholesterol and lipid raft contents as determined by Raman spectroscopy mapping and total internal reflection fluorescence microscopy analyses and by an increase in cellular content of phosphorylated myosin II light chain. Our unexpected findings of this strong metabolic pathway regulation as a response to biomaterial composition highlight the benefits of discovery-driven nonreductionist approaches to gain a deeper understanding of global cellmaterial interactions and suggest alternative research routes for evaluating biomaterials to improve their design. strontium-releasing biomaterials | human mesenchymal stem cells | microarray analysis | sparse feature selection analysis | mevalonate pathway A n important aim of regenerative medicine is to design smart biomaterials to trigger specific biological responses and enable complex tissue repair (1) . Standard in vitro and in vivo testing of such materials usually focuses on assessing the anticipated cell response, often stem cell differentiation to a particular lineage and/or appropriate tissue formation. Although this strategy allows the characterization of specific outcomes, the global cell responses to most biomaterials remain relatively unknown and their mechanisms of action largely unidentified. In comparison with this standard approach, the pharmacology and molecular biology communities have revolutionized their respective fields by taking advantage of unsupervised "-omic" technologies that allow the global biological response to be examined without the inherent bias introduced by predicting particular outcomes. The adoption of comparable hypothesis-generating holistic approaches in the biomaterials communities could stimulate a similar paradigm shift, allowing prospective, rational material design instead of retrospective material evaluation.
With more than 2.2 million bone-grafting procedures carried out annually worldwide, the market for smart biomaterials that can be used as functional alternatives to current autogenic and allogenic grafts is significant (2) . One biomaterial-based regenerative approach involves the incorporation of biologically active moieties into biomaterials to enhance their bone regeneration properties (3) . Strontium ranelate (SrRan) reduces vertebral and nonvertebral fractures in osteoporotic women (4, 5) . Although the mechanism of action of SrRan is not fully understood (6, 7), strontium ions have been reported to be the active component of the drug. Incorporating strontium into biomaterials has been shown to up-regulate osteogenic markers in vitro and osteoconduction in vivo (8) (9) (10) (11) (12) ; however, how such strontium-doped biomaterials improve clinical outcomes and, importantly, how such biomaterials influence the global response of osteoprogenitor cells are largely unknown.
To demonstrate this alternative approach of examining cell response to biomaterials, we applied whole-genome microarray techniques to the classic biomaterial bioactive glass (BG) after incorporation of strontium. Combining an atypical method for recognizing important features in data and Raman spectroscopy mapping, we examined the global response of bone marrowderived human mesenchymal stem cells (hMSC) . Surprisingly, our results show that, rather than directly up-regulating osteogenic genes, strontium-substituted BG (SrBG) strongly regulated the steroid biosynthesis pathway, suggesting a potential mode of action and an alternative avenue for further study. These data show the potential for nonreductionist discovery-driven approaches to transform the design of biomaterials and improve clinical outcomes, particularly in bone regeneration.
Results
Experimental Design. Upon exposure to biological fluids, BGs undergo localized dissolution/reprecipitation reactions, modifying their surrounding ionic environment. To mimic such environments,
Significance
Although new-generation biomaterials are increasingly complex and sophisticated, their development remains largely empirical, and functional outcomes are difficult to predict. Extending the biological evaluation of biomaterials beyond the assessment of preassumed effects would allow a better understanding of the material-driven cell responses. Here we illustrate how applying an objective, nondiscriminative approach to explore the global cell responses to a series of bone substitutes with various compositions can uncover unexpected, important changes at the gene and cellular levels and can provide in-depth knowledge of the effects of specific material properties on cell behavior.
BGs based on the 45S5 composition in which 0, 10, and 100 mol% of calcium was replaced by strontium (Sr0, Sr10, and Sr100, respectively) were incubated with hMSC growth culture medium and subsequently filtered to remove BG particles ( Fig. S1A ), creating BG-conditioned medium. Inductively coupled plasma optical emission spectroscopy (ICP-OES) demonstrated that, although the silicon and phosphate concentrations were similar in all BGconditioned medium compositions, strontium concentrations increased with increasing strontium substitution ( Fig. S1B) .
hMSC from three donors were exposed to SrBG-conditioned medium for 30 min, 2 h, 4 h, 48 h, 5 d, or 10 d, with medium refreshed with new conditioned medium over the course of the experiment. Whole-genome microarray analyses were carried out, and data were examined using an atypical approach to feature selection and an objective functional annotation clustering analysis. Further investigations of cell response were performed using quantitative real-time PCR, Western blotting and in-cell Western blotting, Raman spectroscopy mapping, and total internal reflection fluorescence (TIRF) microscopy.
Regulation of hMSC Gene Expression by BG and SrBG Dissolution
Products. Initial statistical analysis indicated that all BG-conditioned media triggered significant modifications of hMSC mRNA expression in more than 1,000 genes compared with control (CTL) growth medium ( Fig. 1A) . With respect to BG composition, the total number of genes and particularly the number of highly significant differentially expressed (DE) genes increased with increasing strontium substitution, suggesting a more profound modification of the hMSC expression profile with exposure to SrBG dissolution products.
To identify key genes involved in the hMSC response, we analyzed the dataset using an expectation maximization (EM) algorithm. This method of sparse feature selection is an unbiased approach that is very useful for identifying small sets of relevant genes in large microarray datasets in a context-dependent manner by progressively setting the contributions of less relevant genes to zero ( Fig. 1B) (13) . We added two extra hyperparameters, χ and ζ, so that the sparsity of the selection method could be varied (14, 15) .
The EM algorithm method selected a limited set of 11 genes whose expression patterns were altered significantly in the presence of SrBG-conditioned medium. In particular, three of the genes selected by this very sparse selection method acted as clear discriminators between cultures with and without SrBG treatment across the ranges of Sr 2+ concentrations in the experiment (Fig.  1C ). These genes were transmembrane protein 147 (TMEM147), peripheral myelin protein 22 (PMP22), and farnesyl-diphosphate farnesyltransferase 1 (squalene synthase, FDFT1). TMEM147 is a transmembrane protein found exclusively in the endoplasmic reticulum that binds to cholesterol (16) and G protein-coupled receptors (GPCR) (17) . PMP22 (also known as "GAS3") is a glycoprotein associated with lipid rafts (18) that modulates apoptosis, cell morphology, actin stress formation, and migration (19, 20) . FDFT1 is a key mediator of the isoprenoid biosynthesis pathway where it catalyzes the first reaction of the branch committed to sterol biosynthesis. As such, the regulation of FDFT1 directs the formation of either sterol or nonsterol metabolites (21) . Although differences in cell metabolic profiles during hMSC commitment and differentiation have been reported previously (22, 23) , this result represented an unexpected finding because both BG and strontium had been presumed primarily to up-regulate bone formation and/or differentiation of osteoprogenitor cells (7, 24) .
To understand better the global expression modifications in hMSC in response to BG/SrBG treatment, we next applied a functional annotation clustering analysis to the DE genes. When comparing SrBG and CTL conditions, we identified a strong regulation of a cluster of genes in the sterol and steroid biosynthesis pathways ( Fig. 1D and Table S1 ). This cluster showed high enrichment (enrichment score >10) and significance (P < 10 −13 ) and was accompanied by several correlated clusters implicated in sterol and steroid biosynthesis, transport, and homeostasis or fatty acid biosynthetic and metabolic processes. These features were conserved among the Sr100 vs. CTL, Sr10 vs. CTL, and Sr100 vs. Sr0 groups. Such clusters were not identified in the Sr0 vs. CTL condition, suggesting that strontium incorporation played a role in this regulation. Taken together, these results suggest that strontium in BG has a profound effect on the regulation of the steroid/sterol biosynthesis and the associated metabolic processes, supporting our initial finding of the critical role of FDFT1 in response to SrBG.
As has been hypothesized, we also identified the regulation of genes associated with bone development, osteoblast differentiation, and bone mineralization with SrBG treatment ( Fig. 1D and Table S1 ). However, the enrichment scores of these clusters (1.42-1.98) were lower than those described above, and the expression patterns were similar for all BG treatments with no differences identified among BG compositions. For example, hMSC exposed to SrBG medium for 5 d induced up-regulation of secreted phosphoprotein 1 (also known as osteopontin), glycoprotein (transmembrane) nmb, and BMP2 (bone morphogenetic protein 2) compared with CTL (P < 0.05, Sr10 vs. CTL) ( Fig. S2 ). Taken together, these observations suggest that, although genes associated with osteoblast differentiation were indeed differentially regulated in response to BG and SrBG, the effects were subtle and were not strongly affected by strontium. Instead, the primary regulators of hMSC response were genes involved in the sterol and steroid biosynthesis and metabolic processes. Up-Regulation of the Mevalonate and Steroid Biosynthesis Pathways in SrBG-Treated hMSC. Considering that SrBG strongly regulated sterol and steroid biosynthesis and metabolic process clusters, we next asked whether the amount of strontium in BG was also a factor. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses highlighted that, compared with CTL, Sr100 and Sr10 significantly regulated 11 and 13, respectively, of the 13 genes encoding enzymes of the mevalonate pathway and its downstream steroid biosynthesis pathway (Fig. S3A ). These pathways mediate cellular processes including sterol-steroid synthesis, protein prenylation, cell membrane maintenance, and N-glycosylation (25) . Further analyses confirmed similar expression profiles of the enzyme-coding genes from these two pathways ( Fig. 2A and Fig. S3B ), with significant increases in mRNA expression over time up to day 5 correlating with increasing strontium content in BG.
To confirm these observations, we performed RT-PCR on representative genes from these pathways after 5 d of exposure to BG or SrBG (Fig. 2B ). The expression of HMGCS1 [3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)], HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), FDPS (farnesyl diphosphate synthase), and SC4MOL (also known as MSMO1, methylsterol monooxygenase 1) was increased significantly compared with t = 0 and was significantly higher in all cells treated with SrBGconditioned medium than in cells treated with CTL medium. Interestingly, hMSC exposure to Sr0 similarly triggered a significant increase in HMGCS1, HMGCR, and SC4MOL expression. However, Sr100 significantly up-regulated HMGCS1 and HMGCR compared with Sr0, and SC4MOL was significantly up-regulated in Sr100-treated hMSC compared with Sr0 and Sr10 treatment. These experiments corroborated the findings from the microarray dataset, confirming the significant influence of strontium incorporated within BG biomaterials on hMSC gene regulation.
Because gene expression does not necessarily correlate with protein translation, we then sought to evaluate the influence of the regulation of mRNA expression at the protein level with incell Western blots ( Fig. 2C ). Although no significant modification of the amount of HMGCS1 was detected among the various conditions, SrBG treatment significantly increased the cellular content of FDFT1 and geranylgeranyl diphosphate synthase 1 (GGPS1), two key enzymes at the branching point of the isoprenoid pathway (21, 26, 27) . GGPS1, together with FDPS, mediates the protein prenylation process essential for membrane attachment of proteins, whereas FDFT1 controls the synthesis of sterol metabolites, which, after enzymatic modifications, results in the formation of cholesterol. Although the amount of FDFT1 and GGPS1 tended to increase in the Sr10 and Sr100 groups, respectively, compared with the Sr0 group, no significant differences were found between the BG conditions. In accordance with our gene-expression analyses, these differences in protein expression suggested that SrBG-conditioned media influenced both the sterol-and nonsterol-committed branches of the isoprenoid pathway.
Enrichment of Cell Cholesterol and Lipid Content After Exposure
of hMSC to SrBG-Conditioned Medium. Given our observations of dramatic modifications in mRNA and protein expression of enzymes from the mevalonate and steroid biosynthesis pathways, we hypothesized that SrBG treatment also would affect cell sterol metabolite content. Raman spectroscopy is capable of providing detailed biochemical characterization of live cell cultures and is similar to the microarray analyses in that it is a nondiscriminate, unbiased technique (28) (29) (30) . Therefore, we applied Raman spectroscopy mapping to hMSC treated with SrBG-conditioned medium ( Fig. 3 ). The characteristic spectra that were identified by k-means clustering analysis and represent distinctive cell signatures were classified as medium and high cholesterol/lipid content, nucleus, or cytoplasm ( Fig. 3A and Fig. S4 ). This Raman spectrum clustering analysis highlighted clear discrimination between the experimental conditions. The strongest discriminator proved to be cell lipid and cholesterol content, an important end product of the sterol biosynthesis pathway. As shown in Fig. 3 B and C, a significantly higher percentage of lipid/cholesterol-rich spectra per cell was observed in hMSC after exposure to Sr100 than after exposure to CTL medium. These results are in line with our previous findings and indicate that the up-regulation of the sterol biosynthesis pathway triggered an increase in cell sterol metabolites.
hMSC Enrichment of Membranous Cholesterol and Lipid Rafts in
Response to SrBG-Conditioned Medium. Cholesterol is a crucial component of the lipid bilayer of mammalian cell membranes and is a key player in the regulation of physical properties such as rigidity and permeability and of membrane protein clustering and activity (31) . Our observations of up-regulation of FDFT1, which is known to be related to membrane lipid raft content (26) , and increased cell cholesterol content as determined Raman spectroscopy led us to speculate that SrBG biomaterials affected the cellular production of the cholesterol-and sphingolipid-enriched membrane microdomains known as "lipid rafts." Such raft-signaling platforms have been shown to be important for numerous signaling pathways and cell functions. For example, they regulate the activity of various GPCRs and ion channels as well as integrinand small GTPase-mediated signaling events (32) (33) (34) (35) .
To explore this possibility, we used TIRF microscopy to visualize and quantify cholesterol content and lipid rafts at or near hMSC plasma membranes in response to SrBG treatment. We observed significantly higher signal intensity of filipin III on the substratefacing plasma membrane in hMSC treated with Sr100-conditioned medium than in hMSC treated with either Sr0 or CTL medium ( Fig. 4 A and B) . Filipin III binds nonesterified sterols and is used for the identification of cellular cholesterol (36) . To investigate further an effect of SrBG treatment on lipid raft formation, we used FITC-conjugated cholera toxin B subunit (CTB), which has been reported to bind specifically to lipid rafts and is commonly used for their identification (37) . CTB analyses by TIRF revealed significantly higher staining intensity in hMSC exposed to Sr100 than in hMSC exposed to CTL ( Fig. 4 C and D). Taken together, these experiments indicate that the formation of plasma membrane lipid rafts is affected by exposure to SrBG-conditioned medium. Given the broad cell-signaling implications of lipid rafts (35) , this observation opens the intriguing possibility that these particular cell-biomaterial responses may be mediated by changes in the cell plasma membrane.
Increase in the Amount of Phosphorylated Myosin II Light Chain in
SrBG-Treated hMSC. Lipid raft-regulated signaling cascades are modulated through interactions with the actin/myosin meshwork (32, 38) . The communication between the cytoskeleton and lipid rafts is ensured by the presence of several membrane skeleton proteins such as actin, tubulin, or myosin II (38, 39) within these cholesterol-rich domains and is modulated by small GTPases that are targeted to the membrane as a result of FDPS/GGPS1-mediated prenylation. The increase in lipid rafts and FDPS and GGPS1 expression observed in response to SrBG led us to investigate whether SrBG-conditioned media may modulate hMSC actin/ myosin activity further. We quantified the cellular content of the active phosphorylated form of myosin II light chain (pMLC) by Western blotting after hMSC exposure to BG or SrBG for 5 d ( Fig.  4 E and F). Densitometry analyses of pMLC revealed a systematic increase in pMLC content in the Sr10 and Sr100 conditions as compared with the CTL and Sr0 conditions. This result suggested that strontium incorporated within the BG had an effect on the actin/myosin meshwork, which is already known to be an important regulator of hMSC commitment (40, 41) .
Discussion
Here, we exploited the potency of unbiased, nontargeted approaches to investigate how changes in the local cellular environment triggered by strontium substitution in BG influences global hMSC response. Cell-culture models based on conditioned media have been used widely in previous studies (8, 24, 42, 43) , because the local ion content near the material's surface upon implantation is likely to affect the cellular response, along with its surface properties (44) . The strontium concentration in SrBGconditioned media was dependent on the level of Sr substitution in BG (0 mM, 0.1 mM, and 1 mM for Sr0, Sr10, and Sr100, respectively). Such concentrations are likely to be clinically relevant, because the median strontium serum concentration in patients treated with SrRan is 0.12 mM (4), and 1 mM has been used as a reference concentration in several in vitro studies (45, 46) . Our whole-genome microarray analyses revealed the influence of SrBG on hMSC gene expression, with more profound effects observed in groups treated with higher levels of strontium in the biomaterial. Subsequent analyses of the array data demonstrated an increased expression of genes encoding enzymes from the mevalonate and sterol biosynthesis pathways, suggesting strong up-regulation of the sterol and steroid biosynthesis and metabolic processes and protein prenylation activity. These differences were translated to the protein and cellular levels as determined by in-cell Western blot and cholesterol content measurements by Raman spectroscopy. We observed that, as did Sr10 and Sr100, Sr0 exerted a mild effect on many processes, suggesting an influence of the BG-modified ionic environment itself. However, a correlation between the amount of strontium incorporated A C B Fig. 3 . Raman spectroscopy mapping evidence of increased cholesterol and lipid content in hMSC treated with Sr100 medium. Raman spectroscopy mapping was performed on hMSC treated for 5 d with CTL, Sr0, or Sr100 medium. (A) Characteristic spectra identified by k-means cluster analysis of cell-distinctive signatures. Characteristic spectra were classified as nucleus (blue), cytoplasm (green), medium lipid/cholesterol content (yellow), and high lipid/cholesterol content (red). Arrowheads mark characteristic differences among spectra (see within BG and the up-regulation of these pathways was supported by significant differences between the Sr100 and Sr0 treatments. Interestingly, Sr100 exposure led to changes in the membrane composition of hMSC as characterized by increases in membrane cholesterol and lipid raft contents, and treatment of hMSC with Sr10 and Sr100 further led to an increase of the amount of cellular pMLC. Such effects on plasma membrane composition and myosin activity were not found in hMSC treated with Sr0, strengthening the hypothesis that the strontium incorporated within BG mediates these important physiological changes. Previous studies assessing the effects of bone-regenerative biomaterials on gene expression using ChIP arrays often focused on specific genes or clusters known to play roles in osteogenesis but were silent on other biological responses. Others have aimed to identify potential key regulators of cell response to biomaterials and have provided lists of DE genes (43, (47) (48) (49) . Although these studies highlight important possibilities, it remains challenging to interpret the importance of individual DE genes outside their biological context or draw conclusions regarding their physiological importance. Here we chose to combine the objectivity of a functional annotation clustering analysis with a sparse feature selection approach that allowed the detection of a small number of biologically significant genes in a context-dependent manner. More than 1,000 genes were significantly regulated in hMSC after treatment with SrBG-conditioned medium, making the task of manually identifying key genes extremely challenging. In contrast, the sparse feature selection method produced models that made biological interpretation simpler because fewer explanatory variables were required; this method previously has been shown to outperform the commonly used support vector machine algorithm (13) . The sparse feature selection method unexpectedly identified genes encoding PMP22, TMEM147, and FDFT1. The up-regulation of the lipid raft-interacting protein PMP22 (18) and the transmembrane protein TMEM147, which is known to bind to cholesterol (16) , appeared coherent with the changes in mRNA expression of FDFT1, which controls the synthesis of sterol metabolites (21) and regulates the lipid raft content of the cell membrane (26) . This finding led us to propose a new hypothesis regarding SrBG regulation of hMSC based on these pathways, membrane cholesterol content, and lipid rafts.
PMP22 was previously highlighted in a microarray-based study as one of the few genes in human osteoblasts up-regulated by treatment with 45S5 BG-conditioned medium (43) , suggesting that PMP22 plays an important role in both osteoblast and hMSC response. However, further analyses were not pursued in previous studies, perhaps because PMP22 failed to fit standard hypotheses regarding cell response to biomaterials and particularly BG. Conversely, our sparse selection analysis led us to investigate the regulation of these genes, directly leading to our discovery of the regulation the sterol synthesis pathway and subsequent modification of membrane cholesterol and lipid rafts in hMSC response to SrBG. This finding is exciting because lipid rafts are dynamic microdomains of the plasma membrane that play key roles in regulating most of the signaling pathways at the cell surface, including EGF receptor, Hedgehog, Ras, and integrin transduction signaling processes (35) , that subsequently lead to the modulation of numerous cell functions (32) . These functions are regulated by the combined influence of cholesterol binding with membrane proteins, such as GPCR, ion channels, or integrins, and the control of their segregation/clustering within raft-signaling platforms through actin/myosin cytoskeleton meshwork (32) . Communication between raft-signaling platforms and the actin/myosin cytoskeleton is essential for the modulation of signaling cascades, and this interaction is mediated by small GTPases (32) . The membrane targeting and subsequent activity of small GTPase proteins requires an initial prenylation step ensured by FDPS and GGPS1. Here, we observed that SrBG treatment not only increased lipid raft content but also up-regulated FDPS and GGPS1 mRNA expression and GGPS1 protein expression. This up-regulation indicated a possible modulation of small GTPase-mediated cell functions, such as cell proliferation, migration, spreading, or cytoskeleton arrangement (33, 50) . For example, phosphorylation of myosin II light chain, which is essential in actin/myosin meshwork activity and cell contractility, is regulated by the rho-family small GPTases (51) and previously has been reported to be reduced after the inhibition of the mevalonate pathway (52) . Moreover, our observation of the increase of active pMLC in the presence of SrBG appeared consistent with the up-regulation of the isoprenoid biosynthesis pathway and demonstrated that strontium incorporation within the BG had an effect on actomyosin activity. This last result is particularly interesting because cytoskeletal arrangement, which is modulated by environmental calcium and strontium (46, 47) , is known to influence hMSC lineage commitment, particularly during osteogenesis (53) , as a result of the modulation of actin/myosin cytoskeletal contraction (40, 41, 49) , and was found to modulate cell metabolic profiles (22) . Together, our data suggest that the up-regulation of the mevalonate and sterol biosynthesis pathways in hMSC and subsequent membrane cholesterol and lipid raft enrichment in response to SrBG likely change membrane protein quantity or activity. Along with the increase of myosin II light chain activity in SrBG-treated hMSC, these effects open the possibility of further cell-signaling modulations.
Analysis of our array data also highlighted effects, although notably less pronounced, of SrBG treatment on the expression of genes involved in osteoblast differentiation, bone development, and mineralization. Although only a few osteoblastic genes were differentially expressed, the expression profiles were consistent with those previously reported in response to modified ionic environments (42, 47) . BMP2, which encodes bone morphogenetic protein-2, was one of the few genes up-regulated by SrBG and is an osteoinductive growth factor whose expression has been shown to increase in response to calcium and strontium (12, 47) . Such gene regulations may suggest a progressive commitment of hMSC toward the osteoblastic lineage in response to SrBG exposure. Under the conditions tested here, we did not identify statistical differences between BG compositions in the regulation of osteoblast-related genes. However, such results may not be surprising, because the in vitro effects of soluble strontium (or SrRan) on osteoblastic activity and gene expression have been shown to be subtle (46) and difficult to discern from the effects of calcium, given that both ions affect several similar pathways (7) .
In a field in which biomaterials design is increasingly complex, it is interesting to note that the simple inclusion of an ion, such as strontium, within a well-characterized material structure can induce important changes in gene expression, metabolic pathways, and the membrane composition of osteoprogenitor cells. However, because the mechanisms of action of material-driven bone regeneration remain to be elucidated, the development of new biomaterials may prove more efficient with methods that better probe the true response of cells to materials. As we show here, the use of objective screening methods can allow the characterization of global cell responses and are not restricted by a priori assumptions. With the development of increasingly complex and active biomaterials, applying such discovery-driven approaches to study biological responses from various classes of materials may be beneficial for the rational design of materials for regenerative medicine applications. The resulting development of in vitro models that effectively predict the efficacy of biomaterials then may streamline the translation of the biomaterials with the highest potential from the bench to the clinic.
Experimental Procedures
Cell Culture. Bone marrow-derived hMSC from three donors were obtained commercially, expanded, and used independently for microarray experiments and subsequent analyses.
BG-and SrBG-Conditioned Medium. BG particles (0, 10, or 100 mol% substitution of calcium with strontium) were incubated in cell culture medium for 24 h at 37°C and then removed.
Microarray Study. hMSC were treated with basal, BG, or SrBG media for 30 min, 2 h, 4 h, 24 h, 48 h, 5 d, or 10 d. After RNA extraction and sample preparation, whole genome expression analyses were performed using Affymetrix HuGene arrays. Data were examined using a sparse feature selection method, functional clustering, and KEGG analyses.
Molecular Biology and Biochemistry. After 5 d, RT-PCR, Western, and in-cell Western blotting were carried out using standard methods to verify expression of genes in the isoprenoid pathway (identified by microarray) and their translation. 3 , and SrCO 3 (all >99%; Sigma-Aldrich) as precursor materials. Precursor materials were mixed, melted at 1,400°C for 90 min, and cast into distilled water allowing the formation of a frit. The frit was collected in a sieve and allowed to dry at 150°C for 1 h before milling. Glass particles (0.1-1.0 mm) were used for the preparation of BG-and SrBG-conditioned media.
Dissolution Ion Medium. BG dissolution ion medium was created by dissolving glass particles in hMSC growth medium (PromoCell GmbH) (6 mg/mL) at 37°C with shaking. After 24 h, glass particles were removed by passing the medium through at 0.2-μm filter, and the SrBG-conditioned media were stored at 4°C before use. To determine the concentrations of calcium, phosphorus, silicon, and strontium in culture medium resulting from the partial dissolution of BG, elemental concentrations of medium samples were determined by ICP-OES using an iCAP6000 Series ICP spectrometer (Thermo Scientific) on at least three independent samples. PromoCell GmbH Supplement Mix was added to dissolution ion medium, and the medium was allowed to equilibrate in a CO 2 incubator at 37°C for at least 4 h before being placed on cell cultures.
Cell Culture. Bone marrow-derived hMSC from three individual donors were purchased from PromoCell GmbH and were expanded routinely in PromoCell GmbH proprietary hMSC growth medium. Cells from each donor were expanded under identical conditions and were used independently for the experiments. The microarray experiment was performed using cells up to passage 5, and cells up to passage 6 were used for the complementary experiments. hMSC were seeded at 20,000 cells/cm 2 unless stated otherwise and were allowed to attach in standard culture medium for 24 h. Medium was then exchanged with standard (CTL) or BG-conditioned (Sr0 [BG] or Sr10 or Sr100 [SrBG]) medium, and cultures were maintained for up to 10 d. Culture medium was exchanged three times per week.
Microarray Experiment. At t = 0 (24 h after cell seeding) and after incubation for 30 min, 2 h, 4 h, 48 h, 120 h, or 240 h in presence of the CTL, BG, or SrBG culture medium, cell lysates were collected for gene microarray analyses and stored at −80°C. Preparation of the samples for the gene microarray analyses was randomized from the extraction of the RNA to the ChIP hybridization to minimize potential batch effects. Total RNA was isolated using the RNeasy Plus Mini kit (Qiagen). RNA quality was assessed using a Nanodrop 2000c spectrophotometer (Thermo Scientific) and an Agilent RNA 6000 NanoKit integrity (Agilent Technologies, Inc.), and only preparations with 260/280 and 260/230 ratios between 1.9 and 2.1 and with a RNA integrity number higher than 9.7 were used in downstream applications. Samples were prepared using the Ambion WT expression kit (Ambion) and Affymetrix fragmentation and labeling kits (Affymetrix) according to the manufacturers' instructions. The samples were hybridized on Affymetrix HuGene-1_0-st-v1 arrays and were scanned. For each of the three donors, one sample per condition and time point was used for this experiment (n = 3).
Microarray data were analyzed using Partek Genomics Suite version 6.5. The microarray data were preprocessed using the robust multichip average approach and were log 2 transformed, followed by mean one-step probe set summarization, giving each gene a single expression value. The dataset quality was assessed using R-Bioconductor using data from the spike in probe sets, principal component analysis (PCA), and hierarchical clustering analysis and by generating various quality control plots such as mean raw signal intensity plots, mean absolute deviation of the residuals plots, and probe cell intensity plots. Differential expression analysis was carried out using Partek's ANOVA using a false discovery rate (FDR)-corrected P value of <0.1 to determine significantly differentially expressed genes. Functional annotation clustering and KEGG analysis were performed using the DAVID Bioinformatics resources 6.7 software (2, 3). The analysis was carried out from the lists of the most differentially expressed genes (P < 0.01) for all BG vs. CTL groups and from the list of DE genes with P < 0.05 for the Sr0 vs. Sr100 group, because of a limited number of highly differentially expressed genes between these conditions. A high classification stringency was used, and clusters with an enrichment score higher than 1.3 were reported.
Sparse Feature Selection Analysis. Statistical inference using frequentist and Bayesian approaches can be very useful for analysis of datasets with many more variables than observations (4-6). The likelihood function, a central concept in these inference methods, is the probability of the data given the parameters and is a function of these parameters. Bayesian approaches are used here because they provide a means to optimize the Bayesian posterior distribution and offer substantial advantages for sparse feature selection (7) . We adopted a Laplacian prior to generate sparsity in the estimate of the parameter vector β, which represents the gene features (8) . Laplacian priors promote sparsity, because they are formally equivalent to regularization with an l 1 norm penalty, p(βjγ) ∝ exp(−γ jj β jj 1 ), where jj β jj 1 = Σ i jβj is the l 1 norm and γ is a hyperprior used to overcome the nondifferentiability of the Laplacian prior at the origin. Learning procedures that use a Laplacian prior that seek to maximize the posterior density p(β i jD) ∝ p(Djβ i )p(β i ) robustly favor values of β i that are exactly 0 over values that are simply close to 0. Figueiredo (9) reported such a sparse probit regression algorithm that uses Laplacian priors to achieve parameter-free adaptive sparseness. This algorithm iteratively sets low-relevance parameters (genes) to zero until only highly relevant parameters remain, such as sparse identifier genes (i.e., PMP22) studied here. The method is illustrated in the cartoon in Fig. 1B (10) . In this work we added two additional hyperparameters, χ and ζ (11, 12) , to allow control model sparsity. We thus are capable of handling millions of variables and a large variety of response types within the one framework, allowing simple and clear biological interpretations.
The sparse feature selection analysis was performed by applying the EM algorithm to the expression data for each of the four culture conditions: CTL, Sr0, Sr10, and Sr100. The four culture treatments were assigned classes of 0, 1, 2, and 3, respectively. An expression level fold ratio cutoff of 1.2 was used to reduce the number of genes presented to the EM algorithm from 32,322 to 1,138. The reduced set of genes was used as independent variables to predict the membership class (CTL, Sr0, Sr10, or Sr100) of the cells in the experiment. The sparse feature selection was quite robust, because the sets of features in the sparser sets generally were subsets of those with lower degrees of imposed sparsity (0.003, 0.03, 0.3). The sparsest models reduced the pool of candidate genes to 11 that were statistically significant to the classification model at the >95% confidence limit. These genes were able to reproduce the class membership of cells with good efficacy. The genes that are reported (Fig. 1C ) were complementary as identified by this method and the differential expression analysis using a FDR-corrected P value of <0.1.
RT-PCR. Results obtained from the microarray dataset were confirmed by quantitative real-time PCR on three sets of samples from independent experiments. At day 5 of treatment, total RNA was extracted as described above and was reverse transcribed into cDNA using the QuantiTect Reverse Transcription Kit (Qiagen), and quantitative real-time PCR was performed using QuantiTect SYBR Green PCR Master Mix (Qiagen). The reactions were performed on a Corbett Rotorgene 6000 (Qiagen). The primer sequences were previously described (13) . The following primers were used: HMGCS1 (forward: 5′-GGGCAGGGCATTATTA-GGCTAT-3′; reverse: 5′-TTAGGTTGTCAGCCTCTATGTT-GAA-3′); HMGCR (forward: 5′-GGCCCAGTTGTGCGTCTT-3′; reverse: 5′-CGAGCCAGGCTTTCACTTCT-3′); FDPS (forward: 5′-CTTCCTATAGCTGCAGCCATGTAC-3′; reverse: 5′-GCATTGGCGTGCTCCTTCT-3′); SC4MOL (forward: 5′-GA-AAAGCCGGCACCAAGA-3′; reverse: 5′-TCAAAGAGAGAA-TCAGCTCAAACTG-3′); RPL32 (forward: 5′-TTCCTGGTCCA-CAACGTCAAG-3′; reverse: 5′-TGTGAGCGATCTCGGCAC-3′). The results were normalized to the RLP32 housekeeping gene and were represented as mRNA expression values relative to t = 0, using the ΔΔCt method.
In-Cell Western Blotting. hMSC were cultured as previously described in the presence of CTL or glass-conditioned medium for 5 d. The samples were fixed in 3.7% (vol/vol) formaldehyde in PBS for 15 min, and were washed with PBS. The samples were permeabilized using 0.25% (vol/vol) Triton X-100/PBS for 2 min, were washed with PBS, and were blocked for 1 h with 3% (wt/vol) BSA in PBS/0.1% Tween-20 at room temperature. Primary antibodies against HMGCS1, FDFT1, and GGPS1 [rabbit anti-HMGCS1 (ab87246, 1:400), mouse anti-FDFT1 (ab119267, 1:200), mouse anti-GGPS1 (NBP2-03037, 1:200), all from Abcam] were added in 3% (wt/vol) BSA in PBS/0.1% (vol/vol) Tween-20 and were incubated with the samples for 1.5 h at room temperature. After washing in PBS/0.1% (vol/vol) Tween-20, the samples were incubated with anti-rabbit (1:2,000; Li-Cor Biosciences) or antimouse (1:400; Li-Cor) IR800-labeled secondary antibodies for 1 h at room temperature. DNA dye DRAQ5 (1:2,000; New England Biolabs) in 3% (wt/vol) BSA in PBS/0.1% (vol/vol) Tween-20 was added to the solution for normalization, and samples were washed with PBS/0.1% (vol/vol) Tween-20 before staining quantifications using the Odyssey Infrared Imager (Li-Cor Biosciences). Control wells stained only with secondary antibody were used to identify the background signal. After background signal removal, the protein-staining abundance was normalized to the DRAQ5 staining intensity. The quantification was expressed relative to the CTL sample at the same time point.
Western Blot. After 5 d of culture in CTL or BG/SrBG-conditioned medium, hMSC were washed once in ice-cold PBS and were lysed with RIPA buffer [50 mM Tris·HCl (pH 7.4), 150 mM NaCl, 1% (vol/vol) Triton X-100] supplemented with protease inhibitor mixture (Sigma). Lysates were sonicated (five cycles of 5 s) on ice, centrifuged for 20 min at 10,000 × g at 4°C, supplemented with 2× Laemmli buffer (1: 1), and denatured at 100°C for 5 min. Proteins were separated using 15% SDS/PAGE, were transferred onto nitrocellulose membranes, and were blocked with 5% (wt/vol) BSA in TBST [20 mM Tris·HCl (pH 7.6), 136 mM NaCl, and 0.1% (vol/vol) Tween-20] for 1 h. The membranes were incubated with primary antibodies [anti-GAPDH (Santa Cruz) and phospho-myosin II light chain (Ser-19) (Cell Signaling)], both at 1:500 overnight at 4°C. IRDye 800CW donkey anti-rabbit IgG (1:500; LiCor) was used as secondary antibody and analyzed with Odyssey LiCor Software (LiCor).
Raman Spectroscopy Mapping and Analysis. hMSC were seeded at 4,000 cells/cm 2 on MgF 2 slides and were cultured in CTL or Sr0or Sr100-conditioned medium for 5 d. The cells then were fixed in 3.7% (vol/vol) formaldehyde in PBS for 15 min and were washed with PBS. All measurements were performed using a Renishaw RM 2000 Raman microscope (Renishaw) equipped with a Melles Griot tunable Argon Ion laser (Melles Griot) running at 514.5 nm with 30 mW at the sample A 60× (NA = 1.0) long-working-distance (2 mm) water-immersion objective (Nikon). For each condition, cell maps were measured at 0.8 μm spatial resolution, 1 s acquisition time per spectrum, and a 600l grating covering the spectral region 512 to 3,035 cm −1 .
For each individual map, noise was reduced using a PCA-based method excluding higher-order components containing only noise. This reduction resulted in 5-10 components (depending on variation, as explained in ref. 14) being retained for each map. For each map, a k-means cluster analysis (15) was used to identify water backgrounds in the map, and the corresponding background spectrum was used to correct the whole map using extended multiplicative signal correction and spectral interference subtraction (EMSC-SIS) (16) to make all maps comparable. Because the maps were measured over a long period, all spectra were interpolated using spline interpolation to correct for small variations in x-axis calibration. In the last step, all spectra from all included cells were combined into one dataset to allow a direct comparison, and EMSC was performed to normalize the spectra. To find characteristic spectra, a k-means cluster analysis (15) was performed for all spectra. This analysis resulted in seven characteristic clusters that could be grouped into three groups explaining the nucleus, high and medium cholesterol content, and cytoplasm (Fig. 3A) . The cluster spectra then were used to fit all of the spectra using a non-negativity-constrained least-squares fit to generate the final abundance images (Fig. 3B ). The cholesterol, cytoplasm, and nucleus contents of the cells were quantified as a percentage calculation for each individual image in which a cluster spectrum was categorized as belonging to one specific group if it had an abundance value over 0.5. The final percentage was calculated relative to the total number of spectra in each image (Fig. 3C ). All Raman data analyses were performed in MatLab 2013a (Mathworks) using scripts written in house.
TIRF Microscopy. hMSC were seeded at 4,000 cells/cm 2 in chambered coverglass systems (Lab-Tek Chambered #1.0 Borosilicate Coverglass System), were treated with CTL or glass-conditioned medium for 5 d, and were stained for cholesterol and lipid rafts using standard procedures. Briefly, cells were fixed with 3.0% (vol/vol) methanol-free paraformaldehyde in PBS at room temperature for 1 h and were washed in PBS. The paraformaldehyde was quenched by incubation of the samples with 0.15% (wt/vol) glycine in PBS and washing in PBS before incubation with filipin III or CTB for detection of cholesterol (17) or lipid rafts (G M1 ganglioside-binding property) (18), respectively. Filipin III [0.05 mg/mL in PBS/10% (vol/vol) FBS] (CAY70440; Cambridge Bioscience) was incubated with the cells for 4 h in the dark at room temperature under constant agitation. FITC-conjugated CTB (0.01 mg/mL in PBS) (C-1655; Sigma) was incubated in the dark overnight at 4°C under constant agitation. Cells were washed with PBS, postfixed with 2% (vol/vol) methanol-free PFA at room temperature for 15 min, and rinsed with PBS before imaging. For TIRF microscopy, samples in PBS were imaged using a Zeiss Axiovert 200 manual inverted microscope with a 488-nm laser diode, a 100×/1.45W Alpha Plan Fluar objective, and a back-illuminated EM-CCD camera (Hamamatsu C9100-13). Resulting 16-bit raw images were background-subtracted and binarized for quantification purposes using ImageJ software.
Statistical Analysis. Statistical analysis for all experiments except the microarray dataset analyses was performed using a one-way ANOVA analysis and Turkey post hoc test on data obtained from at least three independent experiments. Results with P values lower than 0.05 were considered significant. Fig. S1 . Experimental design. (A) Schematic representation of the design of the study. BG with increasing amounts of strontium substituted for calcium (0, 10, and 100 mol%) were prepared and incubated in cell-culture medium for 24 h at 37°C before being filtered to remove the remaining BG particles. These BGand SrBG-conditioned media were used to treat hMSC from 30 min up to 10 d. An Affymetrix ST 1.0 whole-genome microarray was performed, and the datasets of differentially expressed genes were analyzed objectively using an EM algorithm and by functional annotation clustering. Complementary studies were performed after 5 d of treatment with the conditioned media and included RT-PCR and protein expression quantification, Raman spectroscopy mapping, and TIRF microscopy. (B) Table of the ion contents (in mM) of the BG-conditioned media quantified by ICP-OES. Results are expressed as mean ± SD from three independent samples. Fig. S2 . mRNA expression values of osteogenic genes in hMSC exposed to BG-conditioned media. Expression of BMP2, SPP1 (secreted phosphoprotein 1, also known as osteopontin), and GPNMB [glycoprotein (transmembrane) nmb] after 5 d of treatment. Data were obtained from the microarray dataset and are presented as individual points for each donor because of variations in expression values among the donors. (1, 2) . The spectrum representative of the nucleus signature was rich in bands associated with DNA and RNA as shown by the presence of bands at 785, 1,093, 1,121, 1,335, and 1,574 cm −1 . These bands were assigned to DNA, DNA-backbone stretching vibration, the U, T, C (ring-breathing modes in the DNA/RNA bases), and the ring-breathing mode of DNA/RNA and DNA bases, respectively. The red spectrum is characteristic of metabolites with a high cholesterol content as demonstrated by the presence of bands at 717 cm −1 Legend continued on following page because of the presence of choline groups and cholesterol esters at 702, 1,298, 2,850, and 2,885 cm −1 . The green spectra displayed a cytoplasm signature, with low DNA/RNA compared with nucleus spectra, and are lower in lipid content than the high-cholesterol spectra. RABL3, RASL11B, RRAGA, ARFIP2, SEPT14, TUBA8, RAB21,  ARL11, REM1, RAB2A, ARL8B, GPR109A, EFCAB4B, RAB6C,  ARFRP1, ARHGEF5 2.1E-02
The clusters were determined using DAVID Bioinformatics resources 6.7 software. DE genes with a P value <0.01 and <0.05 were used to evaluate the effects of the BG-conditioned medium treatments compared with the CTL group and Sr100 compared with Sr0, respectively. Clusters with enrichment scores >1.3 are represented.
